Science 03 Complete vs. Incomplete
Comparing BORN to alternatives is comparing complete to incomplete.
Exosomes are only one carrier of regenerative messages. Whole-cell products introduce DNA, variability, and risk. BORN delivers the entire characterized footprint — and nothing it shouldn't.
01 The Difference
Complete delivers what incomplete can't.
| Attribute | BORN | Legacy products |
|---|---|---|
| Complete regenerative footprint | ✓ | — |
| Standardized & measured | ✓ | — |
| Potency verified | ✓ | — |
| Contains DNA / living cells | — | ✓ |
| Off-target effects / contraindications | — | ✓ |
| Batch-to-batch consistency | ✓ | — |
02 Measured Concentrations
Where alternatives register zero, BORN is measured.
In BORN's internal analysis, legacy alternatives showed no detectable assay (or amounts too low for therapeutic effect) across the key molecules.
| Molecule |  | Wharton's Jelly | Amnion | PRP | Bone Marrow | Cord Blood |
|---|---|---|---|---|---|---|
| ENA-78 (CXCL5) | ✓ | X | X | X | X | X |
| M-CSF (CSF-3) | ✓ | X | X | X | X | X |
| GRO-alpha (CXCL1) | ✓ | X | X | X | X | X |
| HGF | ✓ | X | X | X | X | X |
| LIF | ✓ | X | X | X | X | X |
| IL-8 (CXCL8) | ✓ | X | X | X | X | X |
| MCP-1 (CCL2) | ✓ | X | X | X | X | X |
| MMP-1 | ✓ | X | X | X | X | X |
| PGE₂ | ✓ | X | X | X | X | X |
"X" denotes zero detectable assay or amounts too low to produce a therapeutic effect. Based on BORN internal data; independent third-party comparison of competitor products is not included.
Reversing the Irreversible